LicianPro

SKYE stock

Skye Bioscience, Inc. Common Stock (SKYE) short interest & short volume · 140K shares short

Skye Bioscience, Inc. Common Stock official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

SKYE short interest fell 5.2% to 140K shares in the Oct 15, 2026 report (4.9 days to cover). Daily short volume averaged 27.2% of volume over the last 20 sessions, up from 26.5% the 20 sessions before, the 6th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
140K
prior 148K
% of float
—
no float on file
Days to cover
4.9
avg vol 29K
Change vs prior report
-5.2%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
25.0%
1K of 5K
20-day average
27.2%
prior 26.5%
Percentile vs own history
6th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: -23.3%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

SKYE's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · SKYE overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-021,2865,14025.0%
2026-10-302,80814,55019.3%
2026-10-292,54611,70421.8%
2026-10-283,0466,60746.1%
2026-10-272,78510,13327.5%
2026-10-2694010,2459.2%
2026-10-231,8437,61624.2%
2026-10-221,58212,90312.3%
2026-10-211,5316,21524.6%
2026-10-201,1013,38232.5%

Healthcare peers with similar quant ratings

SKYE among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

SKYE short interest FAQ

What is SKYE's short interest?

Skye Bioscience, Inc. Common Stock (SKYE) had 140K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does SKYE have?

4.9 days: 140K shares short divided by an average daily volume of 29K for the Oct 15, 2026 period.

Is SKYE short interest rising or falling?

SKYE short interest fell (-5.2%) from 148K to 140K shares in the Oct 15, 2026 report.

Is SKYE a short squeeze candidate?

Lician's squeeze watch scores SKYE 12 out of 100 (low) from the Oct 15, 2026 report: days to cover 12.3/25, change in short interest vs prior report 0/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of SKYE daily volume is sold short?

27.2% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 6th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was SKYE's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Skye Bioscience, Inc. Common Stock (SKYE) was 1,286 shares, 25.0% of 5,140 total volume.

How many SKYE short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Skye Bioscience, Inc. Common Stock (SKYE), from Oct 20, 2026 through Nov 2, 2026.

How did SKYE short volume percent change from the prior cached session?

Cached FINRA short volume for Skye Bioscience, Inc. Common Stock (SKYE) moved from 19.3% on Oct 30, 2026 to 25.0% on Nov 2, 2026, up 5.7 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.